Skip to main content

MoonLake Immunotherapeutics - Class A Ordinary Shares (NQ: MLTX )

53.89 +2.11 (+4.07%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2024 Add to My Watchlist

Other Filings

Form 8-K/A
Source: SEC/Edgar
March 23, 2011
Form 8-K
Source: SEC/Edgar
March 23, 2011
Form 8-K
Source: SEC/Edgar
March 22, 2011
Form 8-K
Source: SEC/Edgar
February 08, 2011
Form 8-K
Source: SEC/Edgar
February 06, 2011
Form 8-K
Source: SEC/Edgar
January 18, 2011
Form 8-K
Source: SEC/Edgar
January 12, 2011
Form 8-K
Source: SEC/Edgar
January 04, 2011
Form POS AM
Source: SEC/Edgar
December 29, 2010
Form 8-K
Source: SEC/Edgar
December 27, 2010
Form 8-K
Source: SEC/Edgar
December 15, 2010
Form D
Source: SEC/Edgar
December 12, 2010
Form 8-K
Source: SEC/Edgar
December 01, 2010
Form 8-K
Source: SEC/Edgar
November 29, 2010
Form 8-K
Source: SEC/Edgar
November 17, 2010
Form 8-K/A
Source: SEC/Edgar
November 03, 2010
Form 8-K
Source: SEC/Edgar
November 02, 2010
Form DEF 14A
Source: SEC/Edgar
October 31, 2010
Form PRER14A
Source: SEC/Edgar
October 27, 2010
Form 8-K
Source: SEC/Edgar
October 20, 2010
Form PRER14A
Source: SEC/Edgar
October 20, 2010
Form PRE 14A
Source: SEC/Edgar
September 28, 2010
Form DEF 14C
Source: SEC/Edgar
September 07, 2010
Form PRE 14C
Source: SEC/Edgar
August 24, 2010
Form 8-K
Source: SEC/Edgar
June 28, 2010
Form 8-K/A
Source: SEC/Edgar
June 28, 2010
Form 8-K
Source: SEC/Edgar
June 10, 2010
Form 8-K
Source: SEC/Edgar
June 08, 2010
Form DEF 14A
Source: SEC/Edgar
June 08, 2010
Form 8-K
Source: SEC/Edgar
May 27, 2010
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.